NCT07258004Not yet recruiting
An Investigation Into the Feasibility of Beetroot Juice Supplementation in People Living With Alzheimer's Disease.
OMNI Brain Health - An Investigation Into the Feasibility of Beetroot Juice Supplementation in People Living With Alzheimer's Disease.
Source: ClinicalTrials.gov · Last updated 2 Dec 2025
Brief summary (registry, in English)
The goal of this clinical trial is to learn if taking a beetroot juice supplement will work in people living with Alzheimer's disease. The main questions it aims to answer are: * Can people living with Alzheimer's disease realistically drink beetroot juice regularly (for example, is it easy to take, free from side effects and acceptable)? * Does drinking beetroot juice twice a day improve health in people living with Alzheimer's disease? Researchers will look at how you managed with the beetroot juice, as well as if there were any improvements in your health measures. Participants will: * Complete testing before and after the intervention for no more than 3 hours each time * Complete a 1-day food diary before testing * Take a beetroot juice supplementation twice daily for 1-week * Keep a note of any problems with the beetroot juice
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 16 Nov 2025
- Start date
- Mar 2026
- Primary completion date
- Jun 2026
- Lead sponsor
- University of the West of Scotland
- Diseases
- Alzheimer disease
- NCT number
- NCT07258004
What you commit to
- Study type: Interventional
- Planned participants: 30
- From Mar 2026 to the primary completion date, Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Use of medication affecting nitrate metabolism (for example proton pump inhibitors, Isosorbide Mononitrate, Sildenafil or Glyceryl Trinitrate).
Other illness
- Advanced or severe Alzheimer's Disease
- Diagnosis of an additional neurological condition
- Allergies to beetroot
Other
- Have used antibiotics in the last month
- Use of mouthwash in the last month
- Unable to provide informed consent
- Taking part in pharmacological trials
Who the study is looking for
- Aged 65-85 years
- Mild or Moderate Alzheimer's disease
- Participants must be able to speak, read, and understand English to participate in this study.
- To support adherence, participants are asked to have a carer, partner, friend, or family member available to assist with reminders to take the shots twice daily.
Age in the registry: 65 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of the West of Scotland Coordinator of this site? Confirm its status | Glasgow | United Kingdom | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.